In the LLC lung carcinoma model, the overall migratory activity was reduced relative to B16 cells (Figure 1C,D), with no significant differences observed among parental, CCRL2-overexpressing, and CCRL2-deficient lines at 14, 18, 24, or 48 h post-insert removal (p > 0.05) (Figure 1C,D). The gene discussed is CCRL2; the disease is lung carcinoma.